Fundraising Fox

Psylink

2 known investors

Psilocybin biosynthesis platform that produces psychoactive molecular entities using yeast-based technology for pharmaceutical research and drug development.

BiotechDeep TechDigital Health

Investors · 2

BSV VenturesVilnius · $5K – $430K
FirstpickVilnius · $110K – $550K

In the news

Lithuania-Based BioTech Startup Psylink Raises Over €500K to Advance Nature-Inspired Mental Health Therapiesarabfounders.net · Jul 2025Coinvest Capital Leads Round for Psylink’s Next-Gen Biotech Solution for Mental Health Innovation | ILTEilte.lt · Jul 2025Lithuanian BioTech platform Psylink raises over €500k for mental health innovation | EU-Startupseu-startups.com · Jul 2025Lithuania’s Psylink raises pre-seed funding to advance sustainable psychedelic compound research - ArcticStartuparcticstartup.com · Jul 2025Psylink raises €501K to develop innovative treatments for mental healten.ain.ua · Jan 2014Press about BSV Ventures (formerly known as Baltic Sandbox Ventures) - BSV Venturesbsv.ventures

Frequently asked questions

What does Psylink do?
Psilocybin biosynthesis platform that produces psychoactive molecular entities using yeast-based technology for pharmaceutical research and drug development.
Who are Psylink's investors?
Psylink's investors include BSV Ventures, Firstpick.